Altimmune, Inc. (ALT) — DEF 14A Filings
All DEF 14A filings from Altimmune, Inc.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Altimmune's 2024 Executive Compensation & Equity Awards Detailed
— Aug 15, 2025 Risk: medium
Altimmune, Inc. filed its DEF 14A on August 15, 2025, for the fiscal year ending December 31, 2024. The filing details executive compensation, including equity -
Altimmune Files Definitive Proxy Statement for Annual Meeting
— Aug 15, 2024 Risk: medium
Altimmune, Inc. filed its definitive proxy statement (DEF 14A) on August 15, 2024, for its annual meeting on September 26, 2024. The filing concerns the solicit
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX